000 01866 a2200529 4500
005 20250517051107.0
264 0 _c20160701
008 201607s 0 0 eng d
022 _a1768-3114
024 7 _a10.1016/j.patbio.2015.06.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeaumont-Epinette, M-P
245 0 0 _aHeavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
_h[electronic resource]
260 _bPathologie-biologie
_cSep 2015
300 _a215-21 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBlood Protein Electrophoresis
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImmunoelectrophoresis
650 0 4 _aImmunoglobulin A
_xblood
650 0 4 _aImmunoglobulin G
_xblood
650 0 4 _aImmunoglobulin Heavy Chains
_xblood
650 0 4 _aImmunoglobulin Light Chains
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xblood
650 0 4 _aMyeloma Proteins
_xanalysis
650 0 4 _aNeoplasm, Residual
650 0 4 _aProspective Studies
650 0 4 _aTreatment Outcome
700 1 _aMoreau, C
700 1 _aBesnard, S
700 1 _aLatute, F
700 1 _aCollet, N
700 1 _aSebillot, M
700 1 _aGrosbois, B
700 1 _aBendavid, C
700 1 _aGuenet, L
700 1 _aDecaux, O
773 0 _tPathologie-biologie
_gvol. 63
_gno. 4-5
_gp. 215-21
856 4 0 _uhttps://doi.org/10.1016/j.patbio.2015.06.001
_zAvailable from publisher's website
999 _c25214165
_d25214165